Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
16.31
-0.26 (-1.57%)
At close: Feb 27, 2026

SHA:600161 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
32,25140,53650,98339,10339,76752,310
Market Cap Growth
-22.07%-20.49%30.38%-1.67%-23.98%79.10%
Enterprise Value
34,06838,97849,02337,84637,74452,384
Last Close Price
16.3120.2325.3219.3819.6328.19
PE Ratio
24.7326.1745.9444.3952.3381.86
Forward PE
19.5329.4839.6339.1445.0467.68
PS Ratio
5.026.729.849.189.6715.18
PB Ratio
2.162.794.003.443.878.67
P/TBV Ratio
3.224.205.694.785.2712.60
P/FCF Ratio
--38.74--561.25
P/OCF Ratio
-49.4521.3034.7340.5674.51
PEG Ratio
3.912.212.212.212.212.21
EV/Sales Ratio
5.306.469.468.889.1815.20
EV/EBITDA Ratio
13.6214.0425.0826.0728.7544.33
EV/EBIT Ratio
15.9615.7728.7329.2732.1549.94
EV/FCF Ratio
-29.73-37.25--562.04
Debt / Equity Ratio
0.020.000.000.040.050.13
Debt / EBITDA Ratio
0.090.020.020.270.380.68
Debt / FCF Ratio
--0.03--8.59
Net Debt / Equity Ratio
-0.11-0.18-0.35-0.29-0.37-0.16
Net Debt / EBITDA Ratio
-0.67-0.95-2.31-2.28-2.91-0.80
Net Debt / FCF Ratio
1.4610.63-3.4314.5225.25-10.16
Asset Turnover
0.400.400.380.350.430.50
Inventory Turnover
0.920.820.990.971.000.85
Quick Ratio
3.063.413.664.256.652.62
Current Ratio
6.016.895.926.289.324.96
Return on Equity (ROE)
12.54%15.48%12.52%11.14%13.12%16.83%
Return on Assets (ROA)
8.31%10.28%7.87%6.59%7.68%9.46%
Return on Invested Capital (ROIC)
13.42%20.35%17.58%15.07%17.54%19.36%
Return on Capital Employed (ROCE)
14.10%16.80%13.20%11.00%10.90%15.90%
Earnings Yield
4.08%3.82%2.18%2.25%1.91%1.22%
FCF Yield
-3.55%-0.61%2.58%-0.58%-0.38%0.18%
Dividend Yield
0.91%0.49%0.49%0.21%0.35%0.25%
Payout Ratio
37.54%15.96%8.47%17.85%21.56%14.54%
Buyback Yield / Dilution
-0.21%-0.21%0.62%-2.79%-7.41%-0.59%
Total Shareholder Return
0.70%0.28%1.12%-2.57%-7.06%-0.35%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.